BioinformaticsbioRxivPreprint
Benchmarking Boltz-2 for Screening of Therapeutic Antibody-Antigen Interactions
Alexandra Fieux-Castagnet, Julian Waton, Alina Glukhonemykh…·Christoforos Anagnostopoulos
The paper benchmarks Boltz-2 for screening therapeutic antibody-antigen interactions, finding weak but above-chance discrimination and limited benefit from extensive sampling.
DOI 10.64898/2026.05.13.724924